Literature DB >> 7058827

Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease.

T F Yü, L Berger.   

Abstract

Inulin clearance was measured in 624 patients with gout, and para-aminohippuric acid (PAH) clearance in 359; Group I consisted of 397 patients with uncomplicated gout; Group II, 191 patients with hypertension and/or ischemic heart disease; and Group III, 36 patients with chronic renal disease. Mean inulin clearance was normal in Group I, slightly depressed in Group II and more markedly decreased in Group III. There was some reduction in PAH clearance in all groups, but not in the very young patients with no complications. A disproportionate reduction in PAH clearance was noted in Groups II and III, particularly in the older patients with longer duration of gout. Uncomplicated gout, except in rare cases of fulminating gout, does not lead to decreased renal hemodynamics. An increased incidence of tophi correlates with decreased renal function, but incidence of renal calculi does not. Renal insufficiency when seen in patients with gout usually correlates with coexistence of hypertension, ischemic heart disease, or primary preexistent renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058827     DOI: 10.1016/0002-9343(82)90593-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  22 in total

1.  The relationship between serum uric acid and chronic kidney disease among Appalachian adults.

Authors:  Loretta Cain; Anoop Shankar; Alan M Ducatman; Kyle Steenland
Journal:  Nephrol Dial Transplant       Date:  2010-05-25       Impact factor: 5.992

2.  Asymptomatic hyperuricaemia.

Authors:  J T Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-18

3.  Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors.

Authors:  Kazuya Tatani; Masahiro Hiratochi; Yoshinori Nonaka; Masayuki Isaji; Satoshi Shuto
Journal:  ACS Med Chem Lett       Date:  2015-01-28       Impact factor: 4.345

4.  Decrease in serum uric acid level following parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  Q Y Duh; R C Morris; C D Arnaud; O H Clark
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 5.  Uric acid and chronic kidney disease: which is chasing which?

Authors:  Richard J Johnson; Takahiko Nakagawa; Diana Jalal; Laura Gabriela Sánchez-Lozada; Duk-Hee Kang; Eberhard Ritz
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

6.  Treatment of Asymptomatic Hyperuricemia: When do you have a good reason to provide therapy?

Authors:  R M Richardson
Journal:  Can Fam Physician       Date:  1991-02       Impact factor: 3.275

7.  Risk of end-stage renal disease associated with gout: a nationwide population study.

Authors:  Kuang-Hui Yu; Chang-Fu Kuo; Shue-Fen Luo; Lai-Chu See; I-Jun Chou; Hsiao-Chun Chang; Meng-Jiun Chiou
Journal:  Arthritis Res Ther       Date:  2012-04-18       Impact factor: 5.156

8.  Ischemia heart disease and greater waist circumference are risk factors of renal function deterioration in male gout patients.

Authors:  Ben Yu-Jih Su; Han-Ming Lai; Chung-Jen Chen; Ying-Chou Chen; Chun-Kai Chiu; Ko-Ming Lin; Shan-Fu Yu; Tien-Tsai Cheng
Journal:  Clin Rheumatol       Date:  2007-11-20       Impact factor: 2.980

9.  Gout and uric acid nephropathy: some new aspects in diagnosis and treatment.

Authors:  W Löffler; H A Simmonds; W Gröbner
Journal:  Klin Wochenschr       Date:  1983-12-15

Review 10.  Uric acid and cardiovascular risk.

Authors:  Daniel I Feig; Duk-Hee Kang; Richard J Johnson
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.